AHA to CMS Re: Medicare Program: Electronic Prescribing of Controlled Substances; Request for Information (RFI)

AHA provides input on the Centers for Medicare & Medicaid Services’ (CMS) Request for Information (RFI) regarding electronic prescribing of controlled substances (EPCS). The RFI solicits comments on whether CMS should include exceptions to the EPCS requirements laid forth in Section 2003 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, and whether CMS should impose penalties for noncompliance.

Related Resources

Advancing Health Podcast
Public
In this episode, Marie Cleary-Fishman, vice president of clinical quality at the AHA Center for Health Innovation is joined by Dr. Holly Geyer, internal…
Letter/Comment
Public
In a letter to Representatives Bradley Schneider,  David McKinley and Annie Kuster, the AHA expresses support for bipartisan legislation, the Substance Use…
Letter/Comment
Public
In a letter to Senators Margaret Wood Hassan and Susan Collins, the AHA expresses support for bipartisan legislation, the Opioid Workforce Act of 2021 (S. 1438…
Special Bulletin
Public
The House of Representatives early this morning voted 219-212 to approve a modified version of the American Rescue Plan Act of 2021, legislation to provide…
Advancing Health Podcast
Public
In this week’s episode, Marie Cleary-Fishman, vice president of clinical quality at the AHA Center for Health Innovation is joined by Debra Houry, MD, MPH,…
Webinar Recordings
This webinar is presented by: Sarah E. Wakeman, MD Medical Director, Massachusetts General Hospital Substance Use Disorder Initiative Medical Director,…